Aktis Oncology (AKTS) Stock Price & Financial Analysis
Aktis Oncology Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Aktis Oncology
What is the current stock price for AKTS?
As of the latest trading session, AKTS stock trades at $25.02. The 52-week range is $14.72–$34.19, with a day range of $24.23–$26.99.
What is the P/E ratio for AKTS?
The P/E ratio (Price-to-Earnings) for AKTS is shown in the Key Statistics section. This valuation metric helps compare Aktis Oncology, Inc. to industry peers.
Does AKTS pay dividends?
Aktis Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for AKTS?
Based on 3 analysts, the consensus for AKTS is Buy.
What is the market cap of AKTS?
Aktis Oncology's market capitalization is $1.38B, classifying it as a small-cap company. Aktis Oncology operates in the Healthcare sector within the Biotechnology industry.